Granules

Granules India Limited is a prominent Indian multinational pharmaceutical company based in Hyderabad, Telangana. Established in 1984, it specializes in the development, production, and distribution of Active Pharmaceutical Ingredients (APIs), Pharmaceutical Formulation Intermediates (PFIs), and Finished Dosages (FDs). With a strong presence in over 80 countries, including regulated markets like the US and Canada, Granules India has built a reputation for quality and operational excellence. The company operates 10 manufacturing facilities, primarily in India, and has a notable joint venture in Wuhan, China. Its Gagillapur plant is recognized for being the world's largest PFI facility. Granules India invests significantly in research and development, focusing on cost-effective manufacturing processes and innovative drug delivery systems. Its product portfolio includes widely used off-patent drugs such as Paracetamol, Ibuprofen, and Metformin, catering to a diverse customer base of leading pharmaceutical companies globally.